Glenmark Pharmaceuticals Limited (BOM:532296)

Glenmark Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 27, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	427,642	270,463	131,124	124,718	131,124	58,084
Market Cap Growth	88.44%	106.27%	5.14%	-4.88%	125.75%	-68.19%
Enterprise Value	427,246	315,126	164,781	152,778	150,427	81,820
Last Close Price	1516.30	954.77	462.32	436.82	456.74	201.57
PE Ratio	-	-	44.11	13.24	13.52	7.49
PS Ratio	3.25	2.14	1.13	1.01	1.20	0.55
PB Ratio	5.38	3.45	1.33	1.32	1.86	0.96
P/TBV Ratio	6.40	4.15	1.86	1.83	2.77	1.49
P/FCF Ratio	-	743.80	39.15	36.78	12.60
P/OCF Ratio	-	20.97	11.25	11.59	4.17
EV/Sales Ratio	3.06	2.49	1.41	1.24	1.38	0.77
EV/EBITDA Ratio	13.50	17.22	11.53	7.99	7.74	5.49
EV/EBIT Ratio	16.34	21.80	14.48	8.30	8.77	6.30
EV/FCF Ratio	-	934.71	47.96	42.20	17.75
Debt / Equity Ratio	0.21	0.16	0.47	0.42	0.71	0.85
Debt / EBITDA Ratio	0.56	0.64	3.03	1.98	2.45	3.30
Debt / FCF Ratio	-	-	261.38	12.44	13.99	11.25
Asset Turnover	-	0.75	0.64	0.75	0.72	0.76
Inventory Turnover	-	1.87	1.81	1.90	1.74	1.75
Quick Ratio	-	0.75	1.06	1.08	1.00	0.97
Current Ratio	-	1.28	2.10	1.77	1.75	1.65
Return on Equity (ROE)	-	-20.70%	-0.93%	12.04%	14.77%	13.29%
Return on Assets (ROA)	-	5.36%	3.90%	7.04%	7.08%	5.80%
Return on Capital (ROIC)	13.00%	7.68%	5.11%	9.04%	9.20%	7.62%
Return on Capital Employed (ROCE)	-	16.90%	8.00%	14.80%	15.00%	12.30%
Earnings Yield	-0.41%	-5.55%	2.27%	7.55%	7.40%	13.36%
FCF Yield	-4.30%	0.13%	2.55%	2.72%	7.94%
Dividend Yield	0.16%	0.26%	0.54%	0.57%	0.55%	1.24%
Payout Ratio	0.00%	-	23.68%	9.84%	7.26%	8.83%
Buyback Yield / Dilution	0.03%	-0.00%	-	-	-	0.00%
Total Shareholder Return	0.19%	0.26%	0.54%	0.57%	0.55%	1.24%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.